Literature DB >> 11979096

Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.

Jeff D Harvell1, Boris C Bastian, Philip E LeBoit.   

Abstract

This report describes 22 Spitz nevi that seemed to have been clinically removed but persisted and clinically recurred at the biopsy site. These were evaluated in terms of histopathology, immunohistochemistry, and molecular pathology using comparative genomic hybridization (CGH) and fluorescent in situ hybridization. One of these 22 lesions was originally reported as an atypical melanocytic proliferation with some features of a Spitz nevus and was included in the study set at an early stage but was later recognized as melanoma after metastasis to regional lymph nodes 3 years after the local recurrence. We noted four histopathologic patterns in the recurrent lesions: 1) a predominantly intraepidermal pattern resembling "pseudomelanoma" as seen in recurrent "common" melanocytic nevi, 2) a compound, mostly nested pattern above or within a scar that was nearly identical to the originally biopsied Spitz nevus, 3) a nodular growth pattern that closely simulated invasive melanoma, and 4) a desmoplastic pattern resembling an intradermal desmoplastic Spitz nevus. Although the majority of recurrent lesions exhibited asymmetry and pagetoid spread, the dermal component usually had a low mitotic rate and retained architectural and cytologic maturation, which allowed distinction from invasive melanoma. Except for the metastasizing melanoma, the immunostaining pattern with S-100 and HMB-45 was identical to that previously reported for Spitz nevi. Ki67 revealed a very low proliferation rate in all cases, including the melanoma. CGH performed in 10 cases yielded results consistent with Spitz nevi in eight cases. The remaining two cases showed CGH profiles more typical of melanoma, and one of these was the above-referenced case of melanoma, proven by metastasis. Although ancillary molecular techniques such as CGH are of great help in distinguishing these from melanoma, until such techniques become widely available we advocate complete but conservative excision of any recurrent Spitz nevus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979096     DOI: 10.1097/00000478-200205000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Spitz nevi and other Spitzoid lesions part II. Natural history and management.

Authors:  Su Luo; Alireza Sepehr; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2011-12       Impact factor: 11.527

2.  Spitz nevi and other Spitzoid lesions part I. Background and diagnoses.

Authors:  Su Luo; Alireza Sepehr; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2011-12       Impact factor: 11.527

3.  [DNA copy number changes in the diagnosis of melanocytic tumors].

Authors:  J Bauer; B C Bastian
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

4.  [Spitz nevus vs 'spitzoid' malignant melanoma. A diagnostic dilemma?].

Authors:  A Rütten
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

Review 5.  The Spectrum of Spitz Melanocytic Lesions: From Morphologic Diagnosis to Molecular Classification.

Authors:  Tiffany W Cheng; Madeline C Ahern; Alessio Giubellino
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

6.  Intra-oral Spitz naevus: a case report.

Authors:  Ruth Lopes de Freitas Xavier; Marcelo Gadelha Vasconcelos; Hébel Cavalcanti Galvão; Roseana de Almeida Freitas; Evânia Leiros de Souza; Leão Pereira Pinto
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

7.  Recurrent nevi: report of three cases with dermatoscopic-dermatopathologic correlation.

Authors:  Philipp Tschandl
Journal:  Dermatol Pract Concept       Date:  2013-01-31

Review 8.  Time to reconsider Spitzoid neoplasms?

Authors:  Carmelo Urso
Journal:  Dermatol Pract Concept       Date:  2016-04-30

9.  A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma.

Authors:  Arnaud Uguen; Matthieu Talagas; Sebastian Costa; Sandrine Duigou; Stéphanie Bouvier; Marc De Braekeleer; Pascale Marcorelles
Journal:  Diagn Pathol       Date:  2015-10-26       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.